Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMLX | ELVN | NAMS | ||
| Company | Amylyx Pharmaceuticals Inc | Enliven Therapeutics Inc | Newamsterdam Pharma Company N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 36.13 | 61.01 | 28.00 | ||
| High | 38.83 | 61.21 | 28.31 | ||
| Low | 35.32 | 58.39 | 27.64 | ||
| Last | 38.13 | 58.72 | 28.38 | ||
| Change | +3.02 | -1.35 | +1.13 | ||
| Percent Change | +8.60% | -2.25% | +4.15% | ||
| Volume | 4,720,928 | 332,360 | 376,286 | ||
| 20-Day Average Volume | 3,243,848 | 1,005,851 | 1,089,191 | ||
| Previous | 35.11 | 60.07 | 27.25 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.76 | 57.23 | 28.00 | ||
| 20-Day Raw Stochastic | 96.89% | 63.37% | 41.74% | ||
| 20-Day Relative Strength | 82.39 | 60.06 | 43.79 | ||
| Weighted Alpha | +195.66 | +88.50 | -15.62 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +63.38% since 08/12/26 | +0.81% since 08/12/26 | +0.84% since 08/12/26 | ||
| Low | 21.28 on 08/17/26 | 56.69 on 08/14/26 | 26.01 on 08/14/26 | ||
| High | 38.83 on 08/19/26 | 61.19 on 08/19/26 | 28.29 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +114.93% since 07/17/26 | +9.76% since 07/17/26 | -11.41% since 07/17/26 | ||
| Low | 17.00 on 07/23/26 | 51.39 on 07/20/26 | 25.74 on 08/05/26 | ||
| High | 38.83 on 08/19/26 | 62.32 on 08/05/26 | 32.63 on 07/22/26 | ||
| 3-Month | |||||
| %Chg | +199.45% since 05/19/26 | +45.36% since 05/19/26 | -16.77% since 05/19/26 | ||
| Low | 12.62 on 06/08/26 | 33.45 on 06/08/26 | 25.74 on 08/05/26 | ||
| High | 38.83 on 08/19/26 | 62.32 on 08/05/26 | 37.37 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +172.11% since 02/19/26 | +123.20% since 02/19/26 | -18.96% since 02/19/26 | ||
| Low | 12.44 on 05/19/26 | 25.29 on 02/20/26 | 25.74 on 08/05/26 | ||
| High | 38.83 on 08/19/26 | 62.32 on 08/05/26 | 42.21 on 05/11/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,912,061 | 4,401,389 | 3,257,384 | ||
| Shares Outstanding, K | 111,423 | 73,271 | 119,537 | ||
| Annual Sales, $M | 0 | 0 | 22,500,000 | ||
| Annual Net Income, $M | -144,740,000 | -103,690,000 | -203,820,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 3,700,000 | ||
| Last Qtr Income, $M | -43,420,000 | -32,490,000 | -64,140,000 | ||
| 60-Month Beta | -0.21 | 0.27 | 0.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 08/06/26 | -0.49 on 08/05/26 | -0.52 on 08/05/26 | ||
| Latest Earnings Date | 11/05/26 | 11/11/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | 03/28/18 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||